SynthesisInternational journal of colorectal disease2018

Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.

Thierry Landre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.